Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement

Yasir J Sepah, Masood Umer, Tashfeen Ahmad, Faria Nasim, Muhammad Umer Chaudhry, Muhammad Umar, Yasir J Sepah, Masood Umer, Tashfeen Ahmad, Faria Nasim, Muhammad Umer Chaudhry, Muhammad Umar

Abstract

Background & purpose: Allogenic blood transfusion in elective orthopaedic surgery is best avoided owing to its associated risks. Total knee replacement often requires blood transfusion, more so when bilateral surgery is performed. Many strategies are currently being employed to reduce the amount of peri-operative allogenic transfusions. Anti-fibrinolytic compounds such as aminocaproic acid and tranexamic acid have been used systemically in perioperative settings with promising results. This study aimed to evaluate the effectiveness of tranexamic acid in reducing allogenic blood transfusion in total knee replacement surgery.

Methodology: This was a retrospective cohort study conducted on patients undergoing total knee replacement during the time period November 2005 to November 2008. Study population was 99 patients, of which 70 underwent unilateral and 29 bilateral knee replacement. Forty-seven patients with 62 (49.5%) knees (group-I) had received tranexamic acid (by surgeon preference) while the remaining fifty-two patients with 66 (51.5%) knees (group-II) had did not received any tranexamic acid either pre- or post-operatively.

Results: The mean drop in the post-operative haemoglobin concentration in Group-II for unilateral and bilateral cases was 1.79 gm/dl and 2.21 gm/dl, with a mean post-operative drainage of 1828 ml (unilateral) and 2695 ml (bilateral). In comparison, the mean drop in the post-op haemoglobin in Group-I was 1.49 gm/dl (unilateral) and 1.94 gm/dl (bilateral), with a mean drainage of 826 ml (unilateral) and 1288 ml (bilateral) (p-value < 0.001).

Interpretation: Tranexamic acid is effective in reducing post-operative drainage and requirement of blood transfusion after knee replacement.

Figures

Figure 1
Figure 1
Age groups.
Figure 2
Figure 2
Comparison of transfusion requirement in Osteoarthritis & Rheumatoid arthritis.

References

    1. Cushner FD, F R. Blood loss in total knee arthroplasty. Clin Orth. 1991;269:98–101.
    1. Fragen RJ, S S, Wixson R. et al.Effect of Ketorolac tromethamine on bleeding and requirements for analgesia after total knee arthroplasty. J Bone Joint Surg(Am) 1995;77:998–1002.
    1. Bukart BC, B R, Rorabeck CH. et al.The efficacy of tourniquet release in blood conservation after total knee replacement. Clin Orth. 1994;299:147–52.
    1. Karnezis TA, S S, Wixson RL, Reilly P. The hemostatic effects of desmopressin on patients who had total joint arthroplasty. J Bone Joint Surg(Am) 1994;76:1545–50.
    1. Mylod AG, F M, Muser DE, Parsons JR. Perioperative blood loss associated with total knee arthroplasty. J Bone Joint Surg(Am) 1990;72:1010–2.
    1. Fauno P, S O, Rehnberg V. et al.Prophylaxis for the preventiopn of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg(Am) 1994;76:1814–8.
    1. Goodnough LT, V D, Marcus RE. The relationship between hematocrit, blood lost and blood transfused in total knee replacement. Am J Knee Surg. 1995;8:83–7.
    1. Klenerman L, M I, Chakrabarti R. et al.Changes in the hemostatic system after application of a tourniquet. Lancet. 1977;I:970–2.
    1. Benoni G, C A, Petersson C, Fredin H. Does Tranexamic Acid reduces blood loss after total knee arthroplasty? Am J Knee Surg. 1995;8:88–92.
    1. Petaja J, M P, Myllyla G, Vahtera E. Fibrinolysis after application of a pnematic tourniquet. Acta Chir Scand. 1987;153:647–51.
    1. Martin JW, W L, Milliano MT, Reedy ME. Post operative blood Retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty. 1992;7:205–10. doi: 10.1016/0883-5403(92)90019-M.
    1. Lane GJ, H W, Shah S, Rothman RH, Booth RE Jr, Engh K, Smith P. Simultaneous bilateral versus unilateral total knee replacement arthroplasty. Outcomes Analysis. Clin Orthop. 1997;345:106–12.
    1. Nozoe Tadahiro, M M, Saeki Hiroshi, Ohga Takefumi, Keizo Sugimachi. Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma. Cancer. 2001;92(7):1913–18. doi: 10.1002/1097-0142(20011001)92:7<1913::AID-CNCR1709>;2-8.
    1. Brian McClelland MC. Appropriateness and safety of blood transfusion. BMJ. 2005;330:104–105. doi: 10.1136/bmj.330.7483.104.
    1. Spanh DR, C M. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology. 2000;93:242–55. doi: 10.1097/00000542-200007000-00035.
    1. P O, H. Antifibrinolytic therapy with Cyklopropan in connection with prostatectomy: a double blind study. Scand J Urol Nephrol. 1969;3:177–82. doi: 10.3109/00365596909135401.
    1. Dunn CJ, G K. Tranexamic Acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005–32. doi: 10.2165/00003495-199957060-00017.
    1. Bekasssy Z, A B. Treatment with fibrinolytic inhibitor tranexamic acid: risk for thrombosis? Acta Obstet Gynecol Scand. 1990;69:353–4. doi: 10.3109/00016349009036161.
    1. Kataros D, P M, Snow NJ, Woodland DD, Van Bergan. Tranexamic Acid reduces postbypass blood loss: a double blinded, prospective, randomised study of 210 patients. Ann Thorac Surg. 1996;61:1131–5. doi: 10.1016/0003-4975(96)00022-7.
    1. Hiippala ST, S L, Wennerstrand MI, Arvela JV, Niemel a HM, M antyl a SK, Kuisma RP, Ylinen JE. Tranexamic Acid radically reduces blood loss and transfusions associated with total knee arthroplasty. Anesth Analg. 1997;84:839–44.
    1. Hiippala S, S L, Wennerstrand M. Tranexamic Acid (Cyklopropan) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anesth. 1995;74:534–7. doi: 10.1093/bja/74.5.534.
    1. Benoni G, G H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomized, double blind study of 86 patients. J Bone Joint Surg Br. 1996;78:434–440.
    1. Rosenblatt MA. Strategies for minimizing the use of allogeneic blood during orthopedic surgery. Mt Sinai J Med. 2002;69(1-2):83–7.
    1. Zufferey Paul, F M, Laporte Silvy, Decousus Herve', Mismetti Patrick, Auboyer Christian, Charles Marc Samama, Molliex Serge. Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? Anesthesiology. 2006;105:1034–46. doi: 10.1097/00000542-200611000-00026.
    1. Ip, P P. et al.Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol. 2007;31(8):1215–24. doi: 10.1097/PAS.0b013e318032125e.
    1. Sethna NF. et al.Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102(4):727–32. doi: 10.1097/00000542-200504000-00006.
    1. Chrishantha Abeysenaa HJdS. HIV in South Asia. Medicine. 2005;33(6):42–43. doi: 10.1383/medc.33.6.42.66005.
    1. Ali S, T W, Khan A. Viral hepatitis in children. AFIP Rawalpindi, Pakistan; 1998.
    1. Linda E, Prescott PS. Global Distribution of Transfusion-Transmitted Virus. NEJM. 1998;339(11):776–777. doi: 10.1056/NEJM199809103391118.
    1. Mahfooz ur Rahman AGN, Lodhi Y. Transfusion transmitted HIV &amp; HBV infections in Punjab, Pakista. Pakistan Journal of Medical Sciences. 2002;18(1):18–25.
    1. Mukherjee Rupali T. India to be largest market for knee, hip replacements., in The Times of India. 2007.
    1. Sons Fa. Number of total knee implants supplied to Pakitan. Karachi; 2007.
    1. Aga Khan University Hospital Karachi, Pakistan. Price list.
    1. Gandini G. et al.Preoperative autologous blood donation by 1073 elderly patients undergoing elective surgery: a safe and effective practice. Transfusion. 1999;39(2):174–8. doi: 10.1046/j.1537-2995.1999.39299154732.x.
    1. Trouern-Trend JJ. et al.A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion. 1999;39(3):316–20. doi: 10.1046/j.1537-2995.1999.39399219291.x.
    1. Forgie MA. et al.Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 1998;158(6):610–6. doi: 10.1001/archinte.158.6.610.
    1. Sculco TP, Gallina J. Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics. 1999;22(Suppl 1):s129–34.
    1. Etchason J. et al.The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332(11):719–24. doi: 10.1056/NEJM199503163321106.
    1. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg. 1998;86(1):9–15.
    1. Umlas J. et al.Red cell loss following orthopedic surgery: the case against postoperative blood salvage. Transfusion. 1994;34(5):402–6. doi: 10.1046/j.1537-2995.1994.34594249051.x.
    1. Lee AG. Ischemic optic neuropathy following lumbar spine surgery. Case report. J Neurosurg. 1995;83(2):348–9. doi: 10.3171/jns.1995.83.2.0348.
    1. Stevens WR. et al.Ophthalmic complications after spinal surgery. Spine (Phila Pa 1976) 1997;22(12):1319–24. doi: 10.1097/00007632-199706150-00008.
    1. James ML, Keifer JC. Posterior optic nerve ischemic neuropathy in the setting of phenoxybenzamine therapy after uneventful spinal fusion. J Neurosurg Anesthesiol. 2011;23(2):169–70. doi: 10.1097/ANA.0b013e31820396d6.
    1. Coyle D. et al.Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med. 1999;9(1):21–30. doi: 10.1046/j.1365-3148.1999.009001021.x.
    1. Kasper SM. et al.A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty. Eur J Anaesthesiol. 1998;15(6):669–75. doi: 10.1097/00003643-199811000-00008.
    1. Royston D, van Haaften N, De Vooght P. Aprotinin; friend or foe? A review of recent medical literature. Eur J Anaesthesiol. 2007;24(1):6–14.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel